Abstract
Nitric oxide (NO) synthesized by fetal membranes may act either directly inhibiting myometrium contractility or indirectly interacting with tocolytic agents as prostaglandins (PGs). Here we examined if NO could modulate prostaglandin E(2) 9-ketoreductase (9-KPR) activity in human fetal membranes (HFM). 9-KPR is the enzyme that converts PGE(2) into PGF(2alpha), the main PGs known to induce uterine contractility at term. Chorioamnion explants obtained from elective caesareans were incubated with aminoguanidine (AG), an iNOS inhibitor, or NOC-18, a NO donor. NOC-18 (2mM) increased PGE(2) production and diminished PGF(2alpha) synthesis in HFM. AG presented the opposite effect. When we evaluated the activity of 9-KPR by the conversion of [(3)H]-PGE(2) into [(3)H]-PGF(2alpha) and 13,14-dihidro-15-keto prostaglandin F(2alpha) (the PGF(2alpha) metabolite), we found that NOC-18 inhibited 9-KPR activity. Interestingly, AG did not elicit any effect on 9-KPR but l-NAME, a non-selective NOS inhibitor, significantly increased its activity. Our data suggests that exogenous NO inhibits 9-KPR activity in HFM, thus modulating the synthesis of important labor mediators as PGF(2alpha).
References
Feb 1, 1978·Prostaglandins·M D MitchellA C Turnbull
Oct 24, 1991·Biochemical Pharmacology·U FörstermannF Murad
Apr 1, 1985·British Journal of Obstetrics and Gynaecology·S P BrenneckeA C Turnbull
Jan 1, 1983·Acta Obstetricia Et Gynecologica Scandinavica. Supplement·N WiqvistL Wilhelmsson
Jul 1, 1993·Placenta·L MyattJ S Pollock
Mar 1, 1995·British Journal of Pharmacology·D SalveminiP Needleman
Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·A M FranchiM Gimeno
Nov 1, 1993·Placenta·M D MitchellM S Trautman
Nov 5, 1997·Acta Obstetricia Et Gynecologica Scandinavica·E MarinoniE V Cosmi
Nov 14, 1997·American Journal of Reproductive Immunology : AJRI·A L EisL Myatt
Jan 22, 1998·Human Reproduction·A J ThomsonJ E Norman
Jul 8, 1998·Prostaglandins & Other Lipid Mediators·A GobbettiM Zerani
Nov 20, 1998·American Journal of Obstetrics and Gynecology·C D HsuV Parkash
Apr 9, 1999·Journal of Molecular Endocrinology·D SlaterP Bennett
Feb 29, 2000·Placenta·R J SawdyP R Bennett
Jun 7, 2002·The Journal of Clinical Endocrinology and Metabolism·Sam MesianoRoger Smith
Nov 22, 2002·Biology of Reproduction·Fabian Arechavaleta-VelascoFelipe Vadillo-Ortega
Nov 14, 2003·Endocrine Journal·Kazuyo KakuiShingo Fujii
Dec 4, 2003·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M L RibeiroA Franchi
Citations
Oct 10, 2008·Reproduction, Fertility, and Development·Valeria A SanderAlicia B Motta
Jul 14, 2012·PloS One·Claudia A VercelliAna M Franchi
Jun 2, 2014·Lipids·M MedinaS Jerez
Mar 20, 2016·Placenta·Piotr PierzyńskiTadeusz Laudański
Apr 29, 2015·Experimental Animals·Lu YangChengzhi Chai
Jan 12, 2010·Prostaglandins & Other Lipid Mediators·Y S WeemsC W Weems
Sep 22, 2009·Prostaglandins & Other Lipid Mediators·Y S WeemsC W Weems
Sep 3, 2009·Prostaglandins & Other Lipid Mediators·Y S WeemsC W Weems
Dec 15, 2007·Prostaglandins & Other Lipid Mediators·Y S WeemsC W Weems
Jun 22, 2007·Seminars in Cell & Developmental Biology·A López Bernal
Jul 24, 2007·Prostaglandins & Other Lipid Mediators·Yoshie S WeemsCharles W Weems